Active Ingredient(s):Oritavancin Diphosphate FDA Approved: * March 12, 2021 Pharm Company: *MELINTA THERAP Category:Antibiotics
Oritavancin, sold under the brand name Orbactiv among others, is a semisynthetic glycopeptide antibiotic medication for the treatment of serious Gram-positive bacterial infections. Its chemical structure as a lipoglycopeptide is similar to vancomycin.
The U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have approved oritavancin for treatment of acute bacterial skin and skin structure infections.
* May have multiple approval dates, manufacturers, or labelers.
Kimyrsa 1200 mg/40ml Intravenous Injection, Powder, Lyophilized, for Solution